Authors


Heiner K. Berthold, MD, PhD

Latest:

Disease Management Programs in Type 2 Diabetes: Quality of Care

Disease management programs for diabetes can improve some processes of care, but they do not improve intermediate outcomes beyond doubt.




Michael S. Klinkman, MD, MS

Latest:

Barriers and Facilitators to Managing Social Care in the Digital Era Among Michigan Health Centers

There is widespread interest in understanding the role of health care in meeting social needs. This study examines community-wide activities, resources, and information technology used to manage social care.



Michael Eaddy, PharmD, PhD

Latest:

Cost Analysis of COPD Exacerbations and Cardiovascular Events in SUMMIT

This cost analysis using data from the Study to Understand Mortality and Morbidity in COPD (SUMMIT) trial found that fluticasone furoate/vilanterol reduced the rates and costs of combined chronic obstructive pulmonary disease (COPD) exacerbations and revascularization/cardiovascular events versus placebo.


Annemarie V. Wouters, PhD

Latest:

Synchronization of Coverage, Benefits, and Payment to Drive Innovation

Implementation of payment reform, without a corresponding change to coverage, benefit, and other payment requirements, creates conflicting incentives that may nullify the intended aim of payment reform: to improve health outcomes, while saving costs.



R. Brett McQueen, PhD

Latest:

Comparative Effectiveness of Early Natalizumab Treatment in JC Virus-Negative Relapsing-Remitting Multiple Sclerosis

We estimated the long-term risks and benefits of disease modifying therapies. Benefits were favored by natalizumab with minimal increased risks in the negative anti-JC virus population.



Reed E. Drews, MD

Latest:

Managed Care and Cancer Outcomes for Medicare Beneficiaries With Disabilities

This study showed better outcomes for disabled Medicare patients with breast cancer but not those with lung cancer when they were enrolled in HMOs.






William W. Lawrence Jr, MD

Latest:

A Physician-Friendly Alternative to Prior Authorization for Prescription Drugs

A policy allowing prescribers to write prior authorization criteria directly on the prescription led to decreased gaps in therapy without diminishing drug cost savings.


Yi-Chen Hong, PhD

Latest:

Financial Incentives and Use of Cesarean Delivery: Taiwan Birth Data 2003 to 2007

This study explores whether the policies of financial incentives for the demand and supply sides lowered the Cesarean section rate.





Omar Cardenas, BS

Latest:

Impact of a National Specialty E-Consultation Implementation Project on Access

E-consult implementation grew from 12 to 122 VHA sites with multiple specialties. The adjusted e-consult rate of 1.93/100 consults saved significant patient travel miles and costs.






Robert I. Griffiths, ScD, MS

Latest:

Cost-Effectiveness Analysis of Vagal Nerve Blocking for Morbid Obesity

This lifetime economic analysis demonstrates vagal nerve blocking therapy to be a cost-effective alternative to conventional therapy in class 2 and 3 obesity patients.


Daniel A. Belletti, MA

Latest:

Hypertension Treatment and Control Within an Independent Nurse Practitioner Setting

This cross-sectional retrospective study found comparable blood pressure control rates among patients with hypertension receiving primary care from a nurse practitioner versus a physician.



Neil S. Wenger, MD, MPH

Latest:

Does Medicare Advantage Enrollment Affect Home Healthcare Use?

Medicare Advantage beneficiaries use less home healthcare than do their fee-for-service counterparts, but there is marked regional variation in use by both groups.


Louis B. Harrison, MD

Latest:

Cost Savings in Inpatient Oncology Through an Integrative Medicine Approach

An approach including yoga, holistic nursing, and a "healing environment" can decrease medication use, resulting in substantial cost savings in care of inpatient oncology patients.

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo